Review
Open access
Aug 2026
Interpreting the triglyceride–glucose index and its derived indices in metabolic dysfunction-associated steatotic liver disease: clinical utility and evidence gaps
This review examines the clinical interpretation, biological context, and current limitations of the TyG index and its anthropometric and inflammatory derivatives in MASLD and recommends it be considered a metabolic risk marker rather than a stand-alone diagnostic test for MASLD or MASH.
Longzhou Chen, Yucai Tang, Hao Guo et al.
· Frontiers in Medicine · 0 citations